Equivalency of RT-PCR and immunohistochemistry: fact or factoid
- PMID: 18787946
- DOI: 10.1007/s10549-008-0176-1
Equivalency of RT-PCR and immunohistochemistry: fact or factoid
Comment on
-
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.Breast Cancer Res Treat. 2009 Jul;116(1):131-43. doi: 10.1007/s10549-008-0144-9. Epub 2008 Jul 31. Breast Cancer Res Treat. 2009. PMID: 18668363 Clinical Trial.
Similar articles
-
Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?J Clin Oncol. 2009 Jun 1;27(16):2733; author reply 2734-5. doi: 10.1200/JCO.2009.22.0269. Epub 2009 Apr 20. J Clin Oncol. 2009. PMID: 19380432 No abstract available.
-
Cancer is heterogeneous.J Clin Oncol. 2009 Jun 1;27(16):2732; author reply 2734-5. doi: 10.1200/JCO.2008.21.7646. Epub 2009 Apr 20. J Clin Oncol. 2009. PMID: 19380436 No abstract available.
-
[Estrogen receptor (ER), progesterone receptor (PR)].Nihon Rinsho. 2005 Aug;63 Suppl 8:762-4. Nihon Rinsho. 2005. PMID: 16149634 Review. Japanese. No abstract available.
-
[Estrogen and progesterone receptors].Nihon Rinsho. 2010 Jul;68 Suppl 7:799-802. Nihon Rinsho. 2010. PMID: 20960876 Japanese. No abstract available.
-
Immunohistochemical markers as predictive tools for breast cancer.J Clin Pathol. 2008 Jun;61(6):689-96. doi: 10.1136/jcp.2006.041830. Epub 2007 Nov 23. J Clin Pathol. 2008. PMID: 18037665 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical